← Leaderboards
Simon Melov
Buck Institute For Age Research
$20,261,009
Attributed
$30,501,599
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.6M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$37,350,032 · 16
By mechanism
R01$12,963,207 · 4
U54$11,756,154 · 3
U24$5,316,622 · 1
P01$3,313,523 · 2
UH3$1,819,368 · 1
UG3$872,000 · 1
Top collaborators
- Douglas R Seals10 shared
- Judith Campisi8 shared
- Steven R Cummings6 shared
- Nicholas Joseph Schork6 shared
- Lisa M. Ellerby5 shared
- Francesca E. Duncan3 shared
- Birgit Schilling3 shared
- Daniel Spencer Evans1 shared
Most similar at Buck Institute For Age Research
Same institution · by research overlap
- Gordon J. Lithgow$36,209,543
Others in their field
Top investigators on “Aging”
- Lawrence Corey · Fred Hutchinson Cancer Center$506,603,345
- David R. Weir · University Of Michigan At Ann Arbor$421,002,438
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$351,438,389
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$281,021,854
- George R Seage · Abt Associates, Inc.$218,167,298
- Eric Jeffrey Topol · Cleveland Clinic Lerner Col/Med-Cwru$210,610,900
Research focus
AgingAge RelatedGene ExpressionTissuesCellsPhenotypeTechnologyCell TypeElderlySenescenceCell AgingBaseInsightComplexDesignGene Expression ProfilePathologyResearch PersonnelAgedBiologicalProgramsCharacteristicsPathway InteractionsResponse
Grant awards (67)
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,220,833
U54 · FY2025 · AG
Mapping and validating senescent cells in human muscle, ovary and breast$940,921
U54 · FY2025 · AG · contact PI
Single cell analysis core$285,180
P01 · FY2025 · AG · contact PI
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,390,550
U54 · FY2024 · AG
Mapping and validating senescent cells in human muscle, ovary and breast$940,920
U54 · FY2024 · AG · contact PI
Evaluating diverse technologies for detecting and validating senescent cells in vivo$909,684
UH3 · FY2024 · CA · contact PI
Single cell analysis core$291,000
P01 · FY2024 · AG · contact PI
Geroscience Technology Core$46,061
P30 · FY2024 · AG · contact PI
Senescent cell mapping, identification and validation for human somatic and reproductive tissues$2,237,050
U54 · FY2023 · AG
Evaluating diverse technologies for detecting and validating senescent cells in vivo$909,684
UH3 · FY2023 · CA · contact PI
Mapping and validating senescent cells in human muscle, ovary and breast$890,752
U54 · FY2023 · AG · contact PI
Single cell analysis core$291,000
P01 · FY2023 · AG · contact PI
Geroscience Technology Core$54,842
P30 · FY2023 · AG · contact PI
Mapping and validating senescent cells in human muscle, ovary and breast$1,143,108
U54 · FY2022 · AG · contact PI
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2022 · AG
Role of cellular senescence in cardiovascular aging$738,006
R01 · FY2022 · AG · contact PI
Evaluating diverse technologies for detecting and validating senescent cells in vivo$536,000
UG3 · FY2022 · CA · contact PI
Single cell analysis core$291,000
P01 · FY2022 · AG · contact PI
Geroscience Technology Core$62,923
P30 · FY2022 · AG · contact PI
Role of cellular senescence in cardiovascular aging$36,681
R01 · FY2022 · AG · contact PI
Mapping and validating senescent cells in human muscle, ovary and breast$992,020
U54 · FY2021 · AG · contact PI
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2021 · AG
Role of cellular senescence in cardiovascular aging$855,648
R01 · FY2021 · AG · contact PI
Evaluating diverse technologies for detecting and validating senescent cells in vivo$336,000
UG3 · FY2021 · CA · contact PI
Single cell analysis core$291,000
P01 · FY2021 · AG · contact PI
Role of cellular senescence in cardiovascular aging$177,483
R01 · FY2021 · AG · contact PI
Geroscience Technology Core$46,061
P30 · FY2021 · AG · contact PI
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2020 · AG
Role of cellular senescence in cardiovascular aging$784,023
R01 · FY2020 · AG · contact PI
Role of cellular senescence in cardiovascular aging$60,181
R01 · FY2020 · AG · contact PI
Geroscience Technology Core$46,062
P30 · FY2020 · AG · contact PI
Integrative Resource to Develop Translational Strategies to Promote Longevity$911,738
U24 · FY2019 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2019 · AG
Role of cellular senescence in cardiovascular aging$788,547
R01 · FY2019 · AG · contact PI
Role of cellular senescence in cardiovascular aging$480,373
R01 · FY2019 · AG · contact PI
Role of cellular senescence in cardiovascular aging$177,398
R01 · FY2019 · AG · contact PI
Integrative Resource to Develop Translational Strategies to Promote Longevity$935,369
U24 · FY2018 · AG
Resilience pathways modeling human longevity-promoting ApoE variants in induced pluripotent stem cells$879,592
R01 · FY2018 · AG
Role of cellular senescence in cardiovascular aging$826,376
R01 · FY2018 · AG · contact PI
Integrative Resource to Develop Translational Strategies to Promote Longevity$518,104
U24 · FY2018 · AG
Integrative Resource to Develop Translational Strategies to Promote Longevity$963,198
U24 · FY2017 · AG
Integrative Resource to Develop Translational Strategies to Promote Longevity$988,213
U24 · FY2016 · AG
Integrative Resource to Develop Translational Strategies to Promote Longevity$1,000,000
U24 · FY2015 · AG
Analysis of gene expression and cell function in single cell cortical osteoblasts$198,156
R21 · FY2014 · AR · contact PI
Analysis of gene expression and cell function in single cell cortical osteoblasts$259,356
R21 · FY2013 · AR · contact PI
MITOCHONDRIAL, TAU, AND AGING$437,389
P01 · FY2011 · AG · contact PI
MITOCHONDRIAL, TAU, AND AGING$439,006
P01 · FY2010 · AG · contact PI
MITOCHONDRIAL, TAU, AND AGING$355,198
P01 · FY2009 · AG · contact PI
Core--GENOMICS$159,960
P30 · FY2009 · AG · contact PI
MITOCHONDRIAL, TAU, AND AGING$345,780
P01 · FY2008 · AG · contact PI
Core--GENOMICS$142,245
P30 · FY2008 · AG · contact PI
MITOCHONDRIAL, TAU, AND AGING$286,970
P01 · FY2007 · AG · contact PI
Core--GENOMICS$155,834
P30 · FY2007 · AG · contact PI
Comparative Functional Genomics of Longevity Assurance$371,692
R01 · FY2006 · AG · contact PI
Core--GENOMICS$62,235
P30 · FY2006 · AG · contact PI
Comparative Functional Genomics of Longevity Assurance$377,132
R01 · FY2005 · AG
Core--GENOMICS$60,423
P30 · FY2005 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$498,493
R01 · FY2004 · AG
Comparative Functional Genomics of Longevity Assurance$407,847
R01 · FY2004 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$493,862
R01 · FY2003 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$40,000
R01 · FY2003 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$489,365
R01 · FY2002 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$329,000
R01 · FY2001 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$141,000
R01 · FY2001 · AG
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$138,140
R01 · FY2001 · AG
OXIDATIVE STRESS AND DISEASE$15,000
R13 · FY2001 · NS
MITOCHONDRIAL OXIDATIVE STRESS AND NEURODEGENERATION$354,000
R01 · FY2000 · AG